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Abstract
Background: Whole genome sequencing of bacteriophages suitable for biocontrol of pathogens in food products
is a pre-requisite to any phage-based intervention procedure. Trials involving the biosanitization of Salmonella
Typhimurium in the pig production environment identified one such candidate, FSH19.
Results: This phage was sequenced and analysis of its 157,785 bp circular dsDNA genome revealed a number of
interesting features. FSH19 constitutes another member of the recently-proposed Myoviridae Vi01-like family of
phages, containing S. Typhi-specific Vi01 and Shigella-specific SboM-AG3. At the nucleotide level FSH19 is highly
similar to phage Vi01 (80-98% pairwise identity over the length of the genome), with the major differences lying in
the region associated with host-range determination. Analyses of the proteins encoded within this region by
FSH19 revealed a cluster of three putative tail spikes. Of the three tail spikes, two have protein domains associated
with the pectate lyase family of proteins (Tsp2) and P22 tail spike family (Tsp3) with the prospect that these enable
Salmonella O antigen degradation. Tail spike proteins of Vi01 and SboM-AG3 are predicted to contain conserved
right-handed parallel b-helical structures but the internal protein domains are varied allowing different host
specificities.
Conclusions: The addition or exchange of tail spike protein modules is a major contributor to host range
determination in the Vi01-like phage family.
Keywords: Phage biocontrol, biosanitization, bacteriophage genomics, Salmonella Typhimurium, Myoviridae, P22-
like tail spike, pectate lyase tail spike domain, lipopolysaccharide
Background
The use of virulent bacteriophages (phages) as biological
control (biocontrol) agents against bacterial pathogens is
an expanding field of research aimed at producing sus-
tainable solutions for the control of these pathogens,
and to circumvent problems such as those associated
with the development of multidrug-resistant bacteria [1].
The antimicrobial activities of phages committed to the
cellular lysis of a range of bacterial pathogens have been
reported, which include food pathogens such as Campy-
lobacter jejuni [2-5], Escherichia coli [6-8], and various
Salmonella enterica serovars [4,9,10]. However, despite
the wealth of data regarding the efficacy of phages dur-
ing intervention studies, relatively few phage-derived
products have been developed sufficiently for commer-
cial application. Only in the last few years has there
been an extension of lab-based trials into the food pro-
duction environment, where perhaps the best example is
the recognition of the efficacy and the granting of ‘gen-
erally recognized as safe’ (GRAS) status to bacterio-
phages targeting Listeria monocytogenes by the United
States Food and Drug Administration [11]. There are
two products of note now available commercially-List-
Shield™ (Intralytix Inc., USA) a phage cocktail compris-
ing virulent phages with broad activity against L.
Monocytogenes, and Listex P100™ (EBI Food Safety,
Netherlands). Following GRAS classification both List-
Shield™ and Listex P100™ are now viewed as safe to
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any medium, provided the original work is properly cited.be applied as food biopreservatives on ready-to-eat foods
in the USA. Phage P100 (the active component of Listex
P100) was initially characterized at the genetic level and
in oral toxicity studies by Carlton et al [12]. These stu-
dies showed that P100 had no undesirable genes within
its genome, and caused no ill effects when administered
to rats. Many studies reporting the efficacy of Listex
P100 against L. monocytogenes in various food produc-
tion settings are now available in the literature [13-15].
If more phage-based applications are to reach standards
where they are deemed fit for human/animal consumption
then certain matters pertaining to safety must be taken
into consideration. For instance, phages that show poten-
tial during preliminary studies must adhere to strict cri-
teria if they are to be developed further as antimicrobial
agents [16]. Most importantly, the selected phages must
not possess genes associated with virulence, or those that
may enhance the pathogenic profile of its target [17].
Many examples of phages that are recognized as being
involved in such processes are known, for example, the
Shiga toxin-encoding (Stx) phages-a key virulence factor
of Shiga-toxigenic E. coli (STEC)-are the causative agents
of haemolytic uraemic syndrome (HUS), a major contribu-
tor to disease associated with STEC infection [18,19]. Also,
temperate phages that have the potential to form lysogens
with their host need to be eliminated from trials at the
earliest opportunity. Integration into, and excision out of
the host genome, can lead to the transfer of genes between
the phage and bacterium potentially altering the genetic
profile of both [20]. These undesirable traits are most
often associated with phages belonging to the Podoviridae
(icosahedral head with a short non-contractile tail e.g. Sal-
monella phage P22) or Siphoviridae (icosahedral head
w i t haf l e x i b l en o n - c o n t r a c t i l et a i le . g .p h a g el) families.
However, members of the Myoviridae (icosahedral head
and contractile tail e.g. phage T4) are more often asso-
ciated with an obligately lytic lifecycle. All of these mor-
phological characteristics can be easily discerned when
phages are viewed under a transmission electron micro-
scope, although assumptions as to the genetic nature of a
phage cannot be made on morphological characteristics
alone. Whole genome sequencing of phage isolates
intended for use as biocontrol agents is now considered to
be the ‘gold standard’ in terms of transferring phage-based
applications from the laboratory to everyday use.
Here we report the complete genome sequence of
FSH19, a lytic bacteriophage adapted to infecting a
number of different S. Typhimurium serovars. FSH19
has shown great potential as a biocontrol agent against
S. Typhimurium U288, the most prevalent serovar
found in UK pig production premises [21]. S.T y p h i
phage Vi01 was the first of a recently-proposed new
lineage of Myoviridae to be described. Genetic analyses
of the FSH19 genome reveal that it is a close relative of
phage Vi01, in terms of both DNA and protein
sequences. However, phage Vi01 appears to be restricted
to infecting S. Typhi, possibly due to the presence of a
virulence (Vi) capsule antigen-degrading acetyl esterase
domain incorporated into one of its three tail spikes
[22]. The other completely sequenced member of the
Vi01-like phage lineage is SboM-AG3 that is restricted
to the infection of Shigella spp. [23]. No genes asso-
ciated with either toxicity or lysogeny have been found
within the FSH19 157,785 bp circular dsDNA genome,
nor in any of the Vi01 family of phages. A lack of viru-
lence associated genes in FSH19 will allow its use as a
biocontrol agent, aimed at reducing S. Typhimurium
entering the food chain, and in particular S.T y p h i m u r -
ium U288 from pork production.
Results
Bacteriophage FSH19 characterization
Bacteriophage FSH19 was originally isolated from pig
intestinal contents and has specific activity against S.
Typhimurium serovars [24]. Morphologically the phage
has an icosahedral head with a contractile tail indicating
it to be a member of the Myoviridae (Figure 1). A com-
parison of the lytic profiles of phages FSH19 and Vi01
against a panel of S. enterica S e r o v a r si sg i v e ni nT a b l e
1. The data shows that as expected all the S. Typhimur-
ium strains tested are refractory to infection by Vi01,
whereas S. Typhi BRD948 likewise displays immunity
towards infection by FSH19 but susceptibility to Vi01.
Genome analysis
The FSH19 genome was sequenced from sonicated
DNA fragments using the Roche 454 GS FLX platform
Figure 1 TEM image of FSH19. The presence of an icosahedral
head and contractile tail indicate that FSH19 is a member of the
Myoviridae. Magnification × 43,000. Bar 250 nm.
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Page 2 of 14(17,796 reads), from which a single contig of 157,785 bp
was generated. BlastN analysis of the FSH19 genome
revealed two related genome sequences in the database-
phages Vi01 (Genbank Acc. No. FQ312032) and SboM-
AG3 (Genbank Acc. No. FJ373894). The FSH19 gen-
ome was ordered such that it could be directly aligned
with the existing genomes of Vi01 and SboM-AG3 com-
mencing with the rIIA gene. The GC-content of the
FSH19 genome was determined to be 44.68%, which is
slightly lower than Vi01 (45.22% GC), and considerably
lower than SboM-AG3 (50.39% GC). Alignment of the
nucleotide sequences of FSH19 and Vi01 indicate that
they are highly similar over a large proportion of the
genome (between 80-98% pairwise identity). However,
for a region located between 120-130 Kb on the genome
map this homology breaks down to approximately 70%
identity (and in some instances the conservation is lost
completely). This region contains a cluster of three
putative tail spike reading frames in all of the Vi01-like
phages sequenced to date. At the nucleotide level
FSH19 is somewhat less similar when compared to
SboM-AG3, with homologies ranging from 74-100%
identity over approximately 60% of the genome. Com-
parison of the varying degrees of homology between
FSH19, Vi01, and SboM-AG3 are represented in Figure
2. Otherwise highly similar nucleotide matches were
restricted to components of Escherichia phage PhaxI
(Genbank Acc. No. HQ259289), Serratia phage KSP90
(Genbank Acc. No. AB452990) and Salmonella phage
Det7 (Genbank Acc. No. AM765843).
Initial analysis of the FSH19 genome identified 339
potential open reading frames (ORFs). Following BlastP
and Pfam domain analyses of each potential ORF, the
candidate ORFs were reduced to 166. Each ORF was
then annotated using Vi01 and SboM-AG3 phages as
reference sequences, and categorised as follows:
Hypothetical phage proteins (81), Conserved hypotheti-
cal phage proteins (23), DNA replication (24), Tail mor-
phogenesis (16), Capsid/DNA packaging (7), DNA
maintenance/circularization (6), Putative uncharacter-
ized proteins (3), Regulators (2), Lysis (2), and Putative
homing endonucleases (2). A comparison of the major
proteins of FSH19 with their homologues in Vi01 and
SboM-AG3 is presented in Table 2. Figure 3 shows the
fully annotated FSH19 genome as a circular genetic
map. Using tRNAscan-SE, five tRNA genes were also
identified in a 5 Kb non-coding region of the FSH19
genome at the following nucleotide positions: Methio-
nine tRNA (CAT) 137,703-137,735; Asparagine tRNA
(GTT) 137,806-137,878; Tyrosine tRNA (GTA) 138,497-
138,577; Serine tRNA (GCT) 138,657-138,742; and an
undetermined tRNA 138,749-138,834. For phages
FSH19, Vi01, and SboM-AG3 there exists a set of
tRNA genes located at similar positions in their respec-
tive genomes, some of which display a high degree of
conservation. For example, BlastN analysis of the coding
sequence for tRNA-Serine that is present in all three
phages indicates 100% identity at the nucleotide level.
Two other tRNAs (tRNA-Asparagine and tRNA-Tyro-
sine) are also shared between the group. For FSH19
tRNA-Asparagine, the gene is 100% identical with its
homologue in Vi01 and 95% identical to that of SboM-
AG3, whilst the FSH19 tRNA-Tyrosine shows more
conservation with that of SboM-AG3 (99% identical)
than Vi01 (84% identical). FSH19 also shares a tRNA-
Methionine gene (88% identity) and a tRNA of undeter-
mined specificity (99% identity) with Vi01 that are
absent in SboM-AG3. Phire analysis for phage regula-
tory elements identified a number of sites in the FSH19
genome (Table 3). All of the putative regulatory ele-
ments are found on the non-coding strand (relative to
the transcribed sequences within that region) however
they appear to be associated with ORFs on the opposite
strand. It is quite possible that these elements play a
role in regulating FSH19 gene expression, in an as yet
undetermined manner, but perhaps by the production of
small RNA molecules.
FSH19 tail spikes
Three tail spike genes-tsp1 (bases 120,710-122,641c),
tsp2 (122,702-124,876c), and tsp3 (124,992-127,088c)
were identified during the annotation of FSH19. BlastN
analysis of the tsp1 gene (1932 bp) shows that the
nucleotide sequence has 94% identity with that of Vi01
orf 170c (Vi01 Tsp1) over the first 263 bases, but
beyond this conservation breaks down and no further
nucleotide identities are observed between the two
genes. A similar sequence to tsp1 is present at orf 00207
(SboM-AG3 Tsp1) of SboM-AG3 (64% identity over the
first 390 bases), and a shorter stretch of homology (78%
identity over the first 54 bases) is located within orf
00212 (SboM-AG3 Tsp3). As with Vi01, no further
identity can be observed with tsp1 following these short
stretches of conservation. Other nucleotide alignments
of tsp1 include identities with the Salmonella phage
Det7 tail spike gene (86% identity from bases 360-460),
Table 1 Host range assays of FSH19 and Vi01 (+ = lysis
and-= no lysis).
Salmonella FSH19 Vi01
S. Typhimurium U288 + -
S. Typhimurium DT104 WT + -
S. Typhimurium DT104 NCTC 13348 - -
S. Typhimurium WT (Rawlings) + -
S. Typhimurium WT (Turner) + -
S. Typhimurium LT2 + -
S. Typhi BRD948 - +
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identical from bases 351-485). Aside from these align-
ments, which all span a region covering the first 485
bases of tsp1, no homologies were found in the database
for the region covering bases 485-1932. Alignment of
the tsp2 gene (2175 bp) reveals that only Vi01 and
SboM-AG3 have similar sequences within the database.
As with tsp1, the homologies all span the start of the
gene: 85% identity (bases 1-723) with Vi01 orf 171c
(Vi01 Tsp2-maturation/adhesion protein) and 70% iden-
tity (bases 1-360) with SboM-AG3 orf 00210 (SboM-
AG3 Tsp2). The latter portion of the tsp2 gene does not
align with any sequences in the database. BlastN
searches involving the tsp3 gene (2097 bp) show that
the sequence is highly similar to the Det7 tail spike gene
(85% identity from bases 1-782). To a lesser extent, tsp3
shares sequence homology (84% identity between bases
1-461) with Vi01 orf 172c (Vi01 Tsp3) and orf 170c
(69% identity between bases 1-179). Apart from these
short regions of homology, there are no further identi-
ties between tsp3 and Vi01. Interestingly, no nucleotide
sequence homology was found between tsp3 and SboM-
AG3. Bases 481-667 show a conserved sequence that is
shared between several phage genomes in the database.
Sequence alignments over this region indicate 74-77%
shared identities between various Salmonella phages
including P22, ST104, ST64T, ST160, SE1, and some of
the S. Enteritidis typing phages (SETP) [25]. Interest-
ingly, the sequence is also present in prophage tail
spikes of S. Typhimurium D23580, S. Typhimurium
T000240, S. Heidelberg SL476, and S. Paratyphi A
(strain AKU 12601). As was the case for tsp1 and tsp2
no homologous sequences are found to match the latter
region of the tsp3 gene.
Translation of the tsp gene sequences indicate that
Tsp1 is a 643 amino acid protein (predicted MW ~ 68.9
kDa), Tsp2 is comprised of 724 amino acids (predicted
MW ~ 78.2 kDa), and Tsp3 698 amino acids (predicted
MW ~ 75.8 kDa). Pfam domain searches for each tail
spike indicated significant domain matches for Tsp2
(Pectate lyase domain-family 3 CL0268) and Tsp3 (P22
tail spike family); however no significant domain
Figure 2 Artemis Comparison Tool (ACT) analysis of the genomes of SboM-AG3 (top), FSH19 (middle), and Vi01 (bottom).
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CDS FSH19 coordinates
& amino acid length
Predicted
MW
Pfam domain Amino acid
ID with Vi01
Amino acid ID
with SboM-AG3
RIIA 1-2742 (913) 104,992 None 98% 54%
RIIB 2775-4358 (527) 58,980 None 97% 69%
Putative tail fibre 5502-6311 (269) 27,826 Ig-like I-set domain (CL0011) 86% 86%
DNA topoisomerase II 8523-10,436 (637) 71,862 HATPase c (CL0025) & DNA gyrase B 96% 90%
DNA topoisomerase II
(medium subunit)
10,357-11,769 (470) 53,939 DNA topoisomerase IV 88% 88%
Conserved
uncharacterized protein
13,309-13,929 (206) 23,005 Putative Macro domain of ADP-ribose binding
module (CL0233)
92% 74%
DexA exonuclease 14,263-14,895 (210) 24,438 None 95% 93%
dCMP deaminase 18,704-19,225 (173) 19,460 dCMP cytosine deaminase 1 family-cytidine &
deoxycytidylate deaminase Zn-binding domain
(CL0109)
97% 62%
Conserved
uncharacterized protein
19,227-19,634 (135) 15,378 Bacterial membrane-flanked domain (DUF304) 93% 88%
Head completion
protein
19,845-20,465c (206) 24,189 None 92% 74%
Putative homing
endonuclease
20,465-21,205c (246) 28,205 GIY-YIG catalytic domain (CL0418) No match 34%
T4-like baseplate tail
tube cap
21,259-22,227 (322) 36,142 T4 tail cap family 100% 94%
Baseplate wedge
subunit
22,240-22,797 (185) 21,574 Phage Gp53 family 97% 80%
Loader of T4-like
helicase
26,134-26,796c (220) 26,253 T4 helicase N family 99% 79%
DNA ligase 27,281-28,708c (475) 53,501 ATP-dependent DNA ligase domain (CL0078) 95% 83%
DNA primase-helicase
subunit
31,451-32,875c (474) 54,192 DnaB-like helicase N & C terminal domains 98% 88%
UvsX (RecA-like protein) 33,189-34,274c (361) 40,791 RecA bacterial DNA recombination proteins
(CL0023)
72% 78%
dUTPase 34,789-35,340c (183) 21,114 dUTPase 2 family(CL0231) 69% 63%
Thymidylate synthase 35,903-36,943c (346) 39,216 Thymidylate synthase family 93% 77%
DNA end protector 39,924-40,268c (234) 28,347 None 100% 91%
Baseplate tail tube 40,488-41,624 (378) 42,658 Phage T4 Gp19 family 98% 90%
ssDNA binding protein 41,652-42,683c (343) 38,896 Gp3 DNA binding protein-like domain 98% 77%
Late promoter
transcription factor
43,029-43,331c (100) 11,175 None 100% 70%
Regulatory protein
(FmdB family)
43,264-43,509c (81) 8732 CXXC CXXC SSSS family containing a Zn ribbon
domain (CL0167)
96% 88%
Putative uncharacterized
protein
43,875-44,396c (203) 23,739 RuvC family (crossover junction endoribonuclease
RuvC)
100% 83%
Baseplate hub subunit 45,471-46,274 (267) 30,186 T4 baseplate family 96% 67%
Tail-associated lysozyme 46,781-48,406 (541) 59,023 Gp5 OB family & CHAP domain (CL0125) associated
with peptidoglycan hydrolysis
98% 87%
Baseplate wedge protein 48,471-48,851 (126) 14,124 GPW Gp25 family (gene 25-like lysozyme) 97% 87%
NrdB 50,229-51,332c (367) 42,209 Ribonucleotide reductase small chain domain
(CL0044)
99% 89%
NrdA 51,403-53,730c (775) 88,137 ATP-cone domain, ribonucleotide reductase IgN all
alpha domain & IgC barrel domain
94% 89%
PhoH-like phosphate
starvation-inducible
protein
53,764-54,603c (279) 31,567 PhoH-like protein family (CL0023) 100% 88%
Peptidoglycan binding
protein
54,711-55,505c (264) 28,815 Peptidoglycan binding protein domain (CL0244) &
protein of unknown function (DUF3380)
98% 86%
DNA primase subunit 56,712-57,776c (354) 41,386 None 97% 77%
Conserved
uncharacterized protein
63,656-64,273c (205) 22,902 T4 RegB endoribonuclease family (CL0037) 98% 79%
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NrdA.1 64,978-65,313c (336) 12,934 None 94% 92%
Recombination
endonuclease subunit
65,622-67,955c (777) 88,531 None 98% 72%
Recombination protein
subunit
67,958-69,073c (371) 43,030 None 98% 91%
s factor for late
transcription
69,060-69,854c (264) 30,775 None 90% 77%
Putative homing
endonuclease
69,854-70,576c (240) 27,188 None No match 36%
RNase H 70,587-71,114c (175) 19,878 RNase H domain (CL0219) 97% 71%
ATP-dependent helicase 71,921-73,522c (533) 60,690 None 99% 86%
DNA binding protein 73,778-74,056c (92) 9728 Bacterial DNA-binding protein domain 100% 86%
Conserved
uncharacterized protein
74,140-74,931c (263) 28,556 SPFH domain/Band 7 family (CL0433) 98% No match
Superinfection exclusion
protein
75,137-75,457c (106) 12,562 None 95% No match
ImpD 75,736-76,407c (223) 25,665 None 95% 74%
Acyl carrier protein 80,335-80,687c (110) 12,162 Phosphoantetheine (PP)-binding family (CL0314) 92% 61%
Conserved
uncharacterized protein
84,506-84,925c (139) 15,622 Protein of unknown function (DUF3268) 90% 84%
Putative RegA
translational repressor
89,926-90,390c (154) 18,078 Bacteriophage translational regulator 99% 90%
Clamp loader for DNA
polymerase
90,420-90,842c (140) 16,200 None 98% 76%
Gp44 sliding clamp
holder
90,847-91,836c (329) 37,214 ATPase family (CL0023) 99% 87%
Gp45 sliding clamp
holder
91,914-92,582c (222) 24,510 Gp45 sliding clamp C terminal 99% 82%
Putative type III
restriction enzyme (RE)
93,293-94,792 (499) 57,802 Type III RE subunit (CL0023) & helicase conserved C
terminal domain (CL0023)
95% 81%
Conserved
uncharacterized protein
94,822-95,568c (248) 28,911 PD-(D/E)XK nuclease superfamily 97% 86%
Putative UvsY 95,568-96,023c (151) 17,991 UvsY protein family (recombination, repair, & ssDNA
binding protein
93% 85%
Tail completion protein 96,062-96,559c (165) 18,542 T4 Gp19 family 98% 80%
Major capsid protein 101,588-102,910c
(440)
48,059 Gp23 major capsid protein family 98% 94%
Prohead core scaffold
protein
103,002-103,841c
(279)
30,898 None 96% 74%
Prohead protease 103,888-104,556c
(222)
24,482 Peptidase U9 family (CL0201) 99% 92%
Portal vertex protein of
the head
105,102-106,784c
(560)
63,094 T4 Gp20 family 99% 81%
Tail tube protein 106,852-107,385c
(177)
19,912 T4 Gp19 family 100% 98%
GIY-YIG endonuclease 107,416-107,874c
(152)
17,316 GIY-YIG catalytic domain endonuclease family
(CL0418)
95% 32%
Tail sheath protein 107,933-109,828c
(631)
68,439 Phage sheath 1 family 98% 92%
Large terminase subunit 109,881-112,091c
(736)
84,547 Terminase 6 family 95% 85%
Small terminase subunit 112,072-112,752c
(226)
24,825 DNA packaging family (terminase DNA packaging
enzyme)
98% 74%
Proximal tail sheath
stabilization
112,755-113,453c
(232)
26,979 None 98% 80%
Gp14 neck protein 113,456-114,097c
(213)
24,759 T4 neck protein family 100% 82%
Gp13 neck protein 114,400-115,209c
(269)
31,142 None 99% 87%
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Page 6 of 14similarities were identified for Tsp1. Betawrap analyses
of the amino acid sequences of each tail spike from
FSH19, Vi01, and SboM-AG3 shows that each of these
proteins potentially have the ability to form right-
handed parallel b-helical structures. A comparison of
each FSH19 tail spike protein sequence with those of
Vi01 and SboM-AG3, and other homologous proteins in
the database revealed the N-terminal residues (1-130) of
FSH19 Tsp1 are highly conserved with the correspond-
ing regions in Vi01 Tsp1 (78% ID), SboM-AG3 Tsp1
(75% ID), and to a lesser degree in Vi01 Tsp3 (56% ID).
This N-terminal homology is also shared with the
Table 2 Comparison of F?Φ?SH19 proteins with those of Vi01 and SboM-AG3 (Continued)
Tail spike 1 120,710-122,641c
(643)
68,851 None 67% (res. 1-
171 only)
62% (res. 1-190
only)
Tail spike 2 122,702-124,876c
(724)
78,194 Pectate lyase C (CL0268) 86% (res. 1-
276 only)
73% (res. 1-161
only)
Tail spike 3 124,992-127,088c
(698)
75,785 P22 tail spike family 86% (res. 1-
154 only)
46% (res. 1-179
only)
Haemolysin-type calcium
binding protein
127,168-130,209c
(1013)
108,436 None 81% (res. 1-
418 only)
63% (res. 1-404
only)
Baseplate wedge
subunit
132,287-134,080c
(597)
66,068 None 98% 79%
DNA polymerase 145,442-148,438 (998) 116,583 DNA polymerase family B exonuclease domains
(CL0194 & CL0219)
98% 86%
Putative uncharacterized
protein
148,776-149,615 (279) 32,346 NT5C family 5’ nucleotidase deoxypyrimidine
(CL0137)
97% 80%
Figure 3 A schematic circular map of the FSH19 genome.
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Page 7 of 14Salmonella phage Det7 tail spike (56% ID), and a tail
fibre protein from Enterobacter phage Ecp1 (42% ID). A
sequence motif present in FSH19 Tsp1 G-G-V-G-L-G-
A-W (beginning at residue 143) possibly signifies the
boundary at which the catalytic domain of the tail spike
begins. No such sequence motif is present in Vi01 Tsp1,
however similar sequence motifs are present at analo-
gous positions within SboM-AG3 Tsp1 (G-G-L-S-S-S-
N-W) and Vi01 Tsp3 (G-G-V-G-T-G-A-W). ClustalW2
alignments of phage tail-associated proteins containing
derivatives of these motifs at their N-terminal bound-
aries are shown in Figure 4A. The C-terminus of
FSH19 Tsp1 (residues 300-643) produced no significant
alignments with any known proteins. BlastP analyses of
Vi01 Tsp1 and SboM-AG3 Tsp1 was performed to iden-
tify any functionally-related proteins. However, as with
FSH19 Tsp1, Vi01 Tsp1 produced no significant align-
ments over the C-terminal region with any protein
sequences in the database.
Alignment of FSH19 Tsp2 with Vi01 Tsp2 (matura-
tion/adhesion protein) and SboM-AG3 Tsp2 shows a
high degree of conservation from residues 1-160. At this
point SboM-AG3 sequence homology (73% ID over resi-
dues 1-162) breaks down with no further identity to
either Vi01 or FSH19 Tsp2. Residues 100-403 in FSH19
Tsp2 show a weak but significant relationship with a
phage structural protein/putative tail fibre (orf 00213)
present in SboM-AG3. For FSH19 Tsp2 and Vi01 Tsp2,
homology continues over the first 276 residues (86% ID)
at which point the two sequences completely diverge
from each other. Another region of low homology (resi-
dues 100-316) is also found with a putative tail fibre pro-
tein encoded in the Vi01 genome (Vi01 orf 173c). A
pectate lyase protein family domain (family 3-CL0268)
spanning residues 291-549 was identified during Pfam
analysis of FSH19 Tsp2. The presence of this motif was
further confirmed during BlastP analysis, with a number
of alignments being made with various glycoside degrad-
ing enzymes from a wide range of microorganisms. No
significant alignments with the C-terminus of FSH19
Tsp2 were identified (residues 557-724).
FSH19 Tsp3 alignment with Vi01 Tsp3 shows a high
degree of sequence conservation between their N-term-
inal residues 1-154 (86% ID). However, the correspond-
ing sequence in SboM-AG3 Tsp3 shows similarity over
the first 19 residues before a deletion of 63 amino acids,
after which the homology is restored between the three
tail spike sequences. Interestingly, SboM-AG3 Tsp1
shows a higher degree of conservation with FSH19
Tsp3 over residues 1-139 (46% ID) than does SboM-
A G 3T s p 3 .T h eb o u n d a r ym o t i fG - G - V - G - L - G - A - W
appears in FSH19 Tsp3 at residues 143-150 with analo-
gous sequences in Vi01 (G-G-V-G-T-G-A-W) and
SboM-AG3 (G-G-V-S-S-S-A-W), after which the
sequence homologies between all three tail spikes break
down. Pfam domain analysis of FSH19 Tsp3 identified a
protein domain (residues 159-698) with significant
homology to the P22 tail spike family (PF09251). BlastP
analysis produced alignments with Det7 (the first
reported Myovirus with a podoviral tail spike), P22, and
an u m b e ro fP 2 2 - l i k ep h a g e s .T h eh i g h e s td e g r e eo f
homology was found for the tail spike of Det7 (77% ID
over the first 300 residues). The sequence motif marking
the domain boundary in FSH19 Tsp3 (G-G-V-G-L-G-
A-W) is conserved in Det7. P22 tail spike-like sequences
feature three conserved residues that function as cataly-
tic components of the endo-rhamnosidase activity asso-
ciated with P22 tail spike protein [26,27]. These residues
are located in the substrate binding cleft of the P22 tail
s p i k ea n da r ec o n s e r v e di nFSH19 Tsp3 (Figure 4B:
Glu-359, Asp-392 and Asp-395).
Discussion
Bacteriophage FSH19, a candidate for use as a biocon-
trol agent against Salmonella Typhimurium, was sub-
jected to whole genome sequencing. This process is now
viewed as a pre-requisite to using phages as therapeutic
agents, especially if they are to be introduced into a
food production environment. The presence or absence
of genes associated with toxicity or lysogeny will ulti-
mately govern whether or not a potential phage candi-
date is safe for commercial use. FSH19 was found to
contain no undesirable genes in its 157,785 bp genome
making it an excellent candidate for such applications.
Also, FSH19 constitutes a new addition to the Vi01-like
phage family (along with S. Typhi phage Vi01 and Shi-
gella phage SboM-AG3). In many respects FSH19 is
quite similar to Vi01 with the addition of a putative
homing endonuclease and a putative uncharacterized
protein. Structural genes and those associated with mor-
phology of the phage particle are highly conserved
between FSH19 and Vi01, and to a lesser degree with
S b o M - A G 3 .A n a l y s i so ft h et R N Ag e n e se n c o d e db ya l l
three phages, and their location within each genome
indicates that some of them are possibly derived from a
Table 3 Putative phage regulatory elements identified by
Phire analysis.
Putative phage regulatory elements
From To Sequence
56,300 56,319 TAGCCATGATGTAATTCCTC
79,926 79,945 CGGTCATGATGTATTTCCTT
99,487 99,506 TGGTCATGGTGTAGTTCCTT
101,431 101,450 GTCCCATGATGTATTTCTTC
104,872 104,891 TTTCCATCATGCATCTCCTT
109,822 109,841 TTGCCATAATATCATTCCTT
144,434 144,453 TTGCCATGATGTATTTCCTT
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Det7 Tsp                      PKVVPAGSTPASTGGVGLGAWVSVGDAAFRQEAN-------------KKFKYSVKLSDYS 176 
SETP12 Tsp                    PKVIPAASTPLTAGGISDSAWVAFGDITFRAEAD-------------KKFKYSVKLSDFT 153 
Phi19 Tsp3                    PKTVDAGSTPETSGGVGLGAWLSVGDAAFRQEAN-------------KKFKYSVKLSDYS 176 
k1H Tsp63D sialidase          PKTIPASSSPQSTGGVSEGAWQRAGSVVLRQQISNANGAILYPDLHVARWKDEYDPRAWG 166 
K1G Tsp63D sialidase          PKIIPASSSPQSTGGVADGAWQPVGSVILRQQISDVNGAILYPDLHVARWKDEYDPRAWG 166 
K1F tail fibre                PKNVPAGSTPETSGGIGLGAWVSVGDAALRSQISNPEGAILYPELHRARWLDEKDARGWG 245 
Vi01 Tsp3                     PKVVAAGSTPDNSGGVGTGAWIPVGINSLSGDGGWSRIGSEFGKSLKEHIQSLPSLSAVK 189 
Phi19 Tsp1                    PKTVAPGSTPATTGGVGLGAWVSVGDVSLRSELS---------------KEDGFKYIGYS 172 
SboM-AG3 orf00207             PKSVNAGGTIANTGGLSSSNWVKLDPDALRDELY-------------------SGFYRLT 169 
EcoDS1 gp17                   PKEVPAGSTPSTTGGVGLGAWVSVGDASLRSNLIS---------------DNSINGDALI 230 
EPECa14 tail fibre            PKDVPENSTPESTGGVSLGAWVSVGDASLRSDLIS------------------QETDKGS 293 
SboM-AG3 orf 00210            PKTVNKNSTPQSTGGVSSSAWVSVESKTLGSELLTG-----------------EKASLVG 111 
K. pneumoniae prophage tail   PKTVPIASSPATTGGVRAGGWAYTSDAAIRQNLAADSGAKLVGGLNYVTPEMSGFVTGAG 152 
ViII-E1 maturation/adhesion   PKTVPPGSTPYSSGGTGNGKWMAVDVADVLRKDLAKPTGANLIGIHDTTVGEVLRQKVYI 173 
                             ** :   .:  .:**   . *       .  .                           
 
4B 
ST64T Tsp      GESGVKTWQGTVGSTTSRNYNLQFRDSVVIYPVWDGFDLGAD 400 
ST104 Tsp      GESGVKTWQGTVGSTTSRNYNLQFRDSVVIYPVWDGFDLGAD 400 
P22 Tsp        GESGVKTWQGTVGSTTSRNYNLQFRDSVVIYPVWDGFDLGAD 400 
SETP13 Tsp     GESGVKTWQGTVGSTTSRNYNLQFRDSAVLYPVWDGFDLGAD 421 
SETP12 Tsp     GESGVKTWQGTVGSTTSRNYNLQFRDSAVLYPVWDGFDLGAD 421 
SP6 Tsp        GESGFKTWQGSVGAGTSRNYNLQFRDSVALSPVWDGFDLGSD 287 
Det7 Tsp       GESGFKTYQGSVGGGTARNYNLQFRDSVALSPVWDGFDLGSD 444 
19 Tsp3        GESGTKTYQNEIGGRSARNYRLVFDNITTIQCYYDGIDVNAD 440 
4C 
ST64T Tsp         KLSKTLDSGALYSHINVGPGSGSAWTQLTAISGNTPDAVS 606 
ST104 Tsp         KLSKTLDSGALYSHINGGPGSGSAWTQLTAISGNTPDAVS 606 
P22 Tsp           KLSKTLDSGALYSHINVGPGSGSAWTQLTAISGNTPDAVS 606 
SETP13 Tsp        KLSKTLDSGSVYSHINGGPGSGSAWTEITAISGSSPDAVS 627 
SETP12 Tsp        KLSKTLDSGSVYSRINGGPGSGSAWTEITAIAGSLPDAVS 627 
SP6 Tsp           KLTKTLDSGAIRSTLNGGPGTGSAWTEMTAISGSAPNAVS 493 
Det7 Tsp          KLSATLDSGALRSHLNGYAGSGSAWTELTALSGSTPNAVS 650 
ΦSH19 Tsp3        MGGTTNPSLLMTADCQVATPGGEASIVKLSAIQEGVRVGE 641 
ST64T Tsp         LKVNHKDCRGAEIPFVPDIASDDFIKDSSCFLPYWENNSTSLKALVKKPNGELVR 661 
ST104 Tsp         LKVNHKDCRGAEIPFVPDIASDDFIKDSSCFLPYWENNSTSLKALVKKPNGELVR 661 
P22 Tsp           LKVNHKDCRGAEIPFVPDIASDDFIKDSSCFLPYWENNSTSLKALVKKPNGELVR 661 
SETP13 Tsp        LKINRGDYRAVEIPVAMSALPDNAVRDIGSISMYLEGD--SLKALVRRADGSYTR 680 
SETP12 Tsp        LKINRGDYRAVEIPVAMTVLPDNAVRDNGSISLYLEGD--SLKALVKRADGSYTR 680 
SP6 Tsp           LKINRGDFKATEIPVAPTVLPDEAVRDHSSIALYFDQE--ALWALVKKPNGSLTR 546 
Det7 Tsp          LKVNRGDYKTTEIPISGTVLPDEGVLDINTMSLYLDAG--ALWALIRLPDGSKTR 703 
ΦSH19 Tsp3        FQLNRLGFKHMSIPAAPLQLPESALEHNSSIGFFFGSDG-ALRLLAKKPDGSYVT 695 
ST64T Tsp         LTLATL--- 667 
ST104 Tsp         LTLATL--- 667 
P22 Tsp           LTLATL--- 667 
SETP13 Tsp        LTLA----- 684 
SETP12 Tsp        LTLA----- 684 
SP6 Tsp           MKLA----- 550 
Det7 Tsp          MKLSV---- 708 
ΦSH19 Tsp3        YTL------ 698 
Figure 4 A-C ClustalW2 alignments of sequence motifs in tail-associated proteins (4A), the active site of P22-like tail spikes (4B), and
the C-terminal region of P22-like tail spikes-yellow-sequence motif (residues 585-596 in P22) associated with intertwined region,
green-five-stranded b-sheet and three-stranded b-sheet (residues 601-664 in P22), and red-regions lacking homology in FSH19 Tsp3
(4C).
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images of FSH19 (Figure 1), Vi01 and SboM-AG3 indi-
cate that their morphologies are quite similar. The intri-
cate ‘chandelier-like’ arrangements of tail spikes
attached to the baseplate are visible for all three phages
[22,23]. It seems likely that there are more Vi01-like
phages (such as Escherichia phage PhaxI) capable of
infecting a diverse range of bacterial pathogens to be
discovered for which there are commercial applications.
The modular structure of the three tail spikes found
in FSH19 is potentially the main driving factor behind
host-range determination for this phage. Although no
function can at present be assigned to Tsp1, the other
two tail spikes contain defined protein domains that
provide evidence as to their mode of action. For Tsp2,
the pectate lyase domain indicates that this protein may
well function to modify or cleave glycoside bonds. The
pectate lyase family domain (CL0268) notably contains
proteins with pectate/pectin lyase and pectin methyles-
terase activities. The pectate/pectin lyases are a well-
characterized family of proteins principally involved in
microbial plant pathogenesis. Their primary mode of
action involves the eliminative cleavage of a-1,4 linked
galacturonosyl residues of pectins that are components
of the middle lamella of plant cell walls. The three
dimensional structure of Erwinia chrysanthemi EC16
pectate lyase C (PelC) was first solved by Yoder et al.
[28] and is representative of a family of proteins con-
taining right-handed parallel b-helical structures with
the flexibility to allow protein loops from the stacked
coils to add functionality, for example the formation of
the active site clefts that support enzyme catalysis
[29,30]. Using a similar base architecture pectin methy-
lesterase acts to de-esterify pectin to pectate. Members
of the pectinolytic protein family are represented in pro-
karyotic and eukaryotic microorganisms, and also func-
tion in plants to remodel cell walls [29]. Divergence
from the ancestral sequence over time has allowed dif-
ferent microorganisms to target a range of pectin-like
substrates, while the overall structure has been main-
tained [30]. It is of little surprise that phages have
evolved the ability to acquire these proteins and utilize
their polysaccharide modifying properties. In the case of
FSH19 Tsp2 it could be postulated that the target is the
a-D-galactose (1-4) a-D-mannose linkage found in the
S. Typhimurium O-antigen trisaccharide repeat. Many
phage tail-associated proteins have been found to con-
tain right-handed parallel b-helical structural domains,
for example phages P22 [31], Sf6 [32], HK620 [33] and
Det7 [27]. Moreover the presence of a pectate lyase-type
structure in a phage tail spike protein has previously
been reported for K5 lyase (KflA) of coliphages K5A
and K1-5. KflA targets and degrades the capsular poly-
saccharide of E. coli K5, thus allowing the phage access
to outer membrane receptors [34]. Whilst the precise
identity of the polysaccharide target of FSH19 Tsp2 is
at present unknown, it is possible that this tail spike
plays a major role in host-range determination. Plaque
assays using phages Vi01 and FSH19 against a panel of
S.T y p h i m u r i u ma n dS. Typhi BRD948 indicate that
these phages are specific for their host (Table 1). This is
perhaps not surprising since Vi01 orf 171c (Vi01 Tsp2)
possesses a 9-0-acetyl esterase/acetylxylan esterase
domain (residues 343-445; DUF303) that targets the
acetyl-modification of the S. Typhi Vi capsule [22]. The
pectate lyase domain found in FSH19 Tsp2 is more
than likely involved in the degradation of a polysacchar-
i d ep r e s e n to nt h es u r f a c eo fS. Typhimurium U288.
Anany et al. [23] also report that SboM-AG3 is Shigella-
specific and is unable to form plaques on lawns of any
of the Salmonella, Escherichia,a n dListeria strains
tested.
A protein domain composed of parallel right-handed
b-helices is also found in FSH19 Tsp3-the P22 tail
spike domain. Many tail spike proteins possess an N-
terminal binding domain involved in attaching the pro-
tein to the virion head/tail structure (the sequence of
which is often highly conserved between phages with
similar morphologies), a central catalytic domain (con-
taining the trimeric parallel right-handed b-helices), and
a C-terminal trimerization domain (involved in stabiliza-
tion of the trimeric tail spike). The trimeric b-helices
that form the catalytic domain bind and cleave polysac-
charides present in bacterial lipopolysaccharide (LPS).
P22 tail spike (Gp9) utilizes this endo-rhamnosidase
activity to degrade the Salmonella O antigen [35]. Clea-
vage of a-L-rhamnose (1-3) a-D-galactose found in the
trisaccharide-repeats of S. Typhimurium LPS takes place
on the external surface of the tail spike. The structure
and arrangement of the parallel b-helix tail spike
domains result in a solvent-exposed exterior that fea-
tures the proposed catalytic residues Glu-359, Asp-392,
and Asp-395 [27,36]. The active site residues and their
sequence environments are conserved in FSH19 Tsp3,
and therefore can be postulated to operate in a manner
akin to the P22 tail spike and its relatives. Thus, there is
a possibility that FSH19 Tsp3 acts in two distinct ways.
Firstly, FS H 1 9T s p 3m a yf u n c t i o na sa ni n i t i a ls t e p
towards irreversible adsorption of the phage particle to
its host, hydrolyzing the outer S. Typhimurium LPS
layer in order to provide access to a previously inacces-
sible outer membrane receptor. Secondly, the endo-
rhamnosidase activity associated with P22-like tail spikes
may aid phage progeny in freeing themselves from cellu-
lar debris encountered during host lysis [37].
Tsp3 of FSH19 has an N-terminal sequence similar to
Vi01 orf 172c (Vi01 Tsp3), SboM-AG3 orf 00207
(SboM-AG3 Tsp1) and Det7 tail spike. These phages are
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requirements of having to attach the tail spike to similar
base plate structures more than likely places constraints
on sequence divergence. Likewise, the alignments for
the Podoviridae tail spikes show N-terminal conserva-
tion between related phage, followed by conserved cata-
lytic and C-terminal domains that are shared between
Myoviridae, Podoviridae and Siphoviridae. Interestingly,
P22, ST64T, and ST104 as members of the Podoviridae
are 98-99% identical over their 667 amino acid tail spike
proteins, and similarly Siphoviridae members SETP12
and SETP13 also have almost identical tail spike
sequences. Despite that the SETP 12 and 13 phage
sequences are markedly different from P22, ST64T, and
ST104 over the N-terminal regions; however, they
become conserved between residues 140 to 684. As
noted above, there appears to be sequence divergence
constraints placed on conserved N-terminal regions
associated with the myoviruses FSH19, Vi01, SboM-
AG3 and Det7. Similarly it appears there are structural
restrictions imposed on the Podoviridae and Siphoviri-
dae N-terminal tail spike sequences. Similarities between
FSH19 Tsp3, Det7 and the P22-like sequences begin ten
amino acids after the boundary motif G-G-V-G-L-G-A-
W that appears in FSH19 Tsp3 and Det7 (this motif
also signals the divergence of the tail spike sequences of
phages Vi01 and SboM-AG3 from FSH19 and Det7).
FSH19 Tsp3 and Det7 Tsp show striking conservation
with the P22-like sequences over the catalytic domain,
up to and including the active site residues Glu-359,
Asp-392 and Asp-395. However, immediately after the
active site in FSH19 Tsp3 (residues 440-698) sequence
conservation breaks down.
For P22-like tail spike proteins, the C-terminal residues
585-596 form an intertwined region that allows extensive
hydrogen bonding between subunits, whilst residues 606-
664 form a five-stranded and a three-stranded b-sheet
region [27]. ClustalW2 alignment of these regions show
that all the aligned P22-like tail spikes contain conserved
residues at these locations (including the Myovirus Det7),
t h a ts e tt h e ma p a r tf r o mFSH19 Tsp3 (Figure 4C). The
eight amino acids spanning residues 585-592 (V/G-G-P/
A-G-S/T-G-S-A-W) retain a sequence motif similar to
that found at the N-terminal boundary of FSH19 Tsp3,
and the tail-associated proteins aligned in Figure 4A.
However, this motif is absent at the C-terminal end of
FSH19 Tsp3. P22-like tail spike modules may well have
descended from a common ancestor with the flexibility
to diverge their protein sequences whilst retaining the
topology of the right-handed parallel b-helices. It has
been proposed that this flexibility has allowed the protein
domain to become widespread amongst bacteriophages
[33], with the possibility of later domain interchange
creating further diversity [38].
I ns u m m a r y ,w eh a v es e q u e n c e dt h eg e n o m eo f
FSH19, a promising candidate for phage biosanitization
of S. Typhimurium in the food production environment.
The 157,785 bp circular dsDNA genome was found to
contain no genes associated with toxicity or lysogeny,
which is a pre-requisite for such applications. Analysis
of the nucleotide sequence of FSH19 revealed only two
close relatives in the database: S.T y p h i - s p e c i f i cV i 0 1
and Shigella-specific SboM-AG3 that collectively form
the Vi01-like phage family. Major differences were evi-
dent between FSH19 and Vi01 in three different tail
spike proteins. Two tail spikes from FSH19 contain
protein domains associated with the degradation of
polysaccharides common to Salmonella LPS, namely the
pectate lyase (Tsp2) and P22 tail spike-like (Tsp3)
families of proteins. The acquisition of these domains is
the most obvious reason to explain the different host
specificities of FSH19, Vi01 (seemingly host-restricted
due to the presence of a Vi antigen-degrading tail spike
protein domain) and SboM-AG3 (whose tail spikes are
as yet undefined). Based on amino acid sequence analy-
sis the tail spikes from all three phages appear to form
right-handed parallel b-helical structures. This appears
to be an evolutionarily-conserved structure for all three
tail spikes found in the Vi01-like phage. However, this
conservation is coupled to the exchange of individual
protein domains within these structures that may ulti-
mately determine host range.
Materials and methods
Isolation of FSH19
For phage isolation, sewage effluent was filtered through
0.2 μm Minisart filters (Sartorius Biotech. Cat. No.
16534) and the filtrate collected in sterile universals and
stored at 4°C until required. For S. Typhimurium lawn
preparation NZCYM broth (Difco Cat. No. 240410) cul-
tures were prepared and incubated overnight at 37°C
with shaking. Following this, the overnight culture was
used to seed fresh NZCYM broth containing 10 mM
MgSO4 (Sigma Aldrich Chemicals Cat. No. M2643)
which was then incubated for 2 hours at 37°C with
shaking. To molten (tempered to ~ 50°C) NZCYM top
agar containing 0.6% Bacteriological Agar No.1 (Oxoid
Cat No. LP0011) 500 μL of the required Salmonella was
added, followed by 500 μL filtrate, and the mixture was
poured onto NZCYM agar plates. The plates were left
to set on the bench for 20 minutes before being inverted
then incubated overnight at 37°C. Any plaques identified
were picked using sterile pipette tips and resuspended in
500 μL SM buffer (50 mM Tris-HCl [pH7.5], 100 mM
NaCl, 8 mM MgSO4:7H2O, 0.01% gelatin, pH 7.5), incu-
bated at 37°C for 1 hour, then serial diluted in SM buf-
fer. A 25 μL volume of each dilution was then added to
Salmonella/NZCYM top agar, and lawns were prepared
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times in order to obtain a single clonal isolate of
FSH19.
Phage host range assays
The ability of phages FSH19 and Vi01 to lyse various S.
Typhimurium serovars and S.T y p h iB R D 9 4 8( k i n d l y
provided by D. Pickard Wellcome Trust Sanger Centre,
UK) was determined as follows. S. Typhimurium and S.
Typhi BRD948 top agar lawns were prepared as
described above, with the exception of the latter being
grown on supplemented minimal media as described by
Tacket et al. [39]. To each bacterial lawn triplicate 20
μL volumes of log107 PFU mL
-1 dilutions of the required
phage were applied. Following a sufficient drying period,
plates were inverted and incubated overnight at 37°C.
The following day, each plate was observed for lysis and
the results are shown in Table 1.
Transmission electron microscopy
A freshly-prepared high titre phage suspension of
FSH19 was sedimented at 34,900 × g for 2 hours (4°C).
Following centrifugation, the supernatant was decanted
and each phage pellet was washed twice with 0.1 M
ammonium acetate for 1 hour at 25,000 × g. The wash
solution was discarded and 2 mL SM buffer added to
each centrifuge tube. Phage pellets were recovered fol-
lowing overnight incubation at 4°C with gentle shaking.
A small drop of washed phage suspension was spotted
onto a carbon-coated copper mesh grid and allowed to
sit for 3 minutes. Excess phage suspension was then
removed with filter paper. For negative staining one
drop of phosphotungstic acid [pH 7.4] was added to
each grid, and excess stain was removed one minute
later with filter paper. Each grid was then covered and
allowed to dry for 15 minutes. Images were taken with a
Fei Tecnai Biotwin TEM (Fei Company, USA).
FSH19 DNA extraction and sequencing
A high titre suspension of FSH19 (~ 10
10 PFU mL
-1)
was subjected to a single-step caesium chloride (CsCl)
purification procedure as follows. CsCl (Melfords Cat.
No. MB1006) was added to the high titre phage suspen-
sion to a final concentration of 0.75 g mL
-1. Samples
were then subjected to ultracentrifugation at 264,000 ×
g for 24 hours in a Beckman TL100 ultracentrifuge (15°
C). Extraction of the band containing purified highly-
concentrated FSH19 was then performed with a sterile
20-gauge hypodermic needle, and the band was subse-
quently collected in a sterile tube. Residual CsCl was
removed from the sample using an Amicon
® Ultra-0.5
30 kDa MWCO centrifugal filter device (Millipore Cat.
No. UFC 503008) as follows. Briefly, phage-CsCl solu-
tion was added to the column, which was then spun at
17,900 × g in a benchtop centrifuge for 30 mins. The
column was then washed twice with SM buffer at
17,900 × g for 2 minutes. To elute the retained phage,
SM buffer was added to the column which was then
inverted and placed in a fresh collection tube. The col-
umn was then centrifuged at 17,900 × g for 10 minutes
to recover the phage. FSH19 DNA was isolated from
the purified stock using the phenol-chloroform extrac-
tion method with slight modifications as follows. An
equal volume of 10 mg mL
-1 Proteinase K (Fisher Scien-
tific Cat No. BPE 1700-500) was added to the CsCl-pur-
ified sample, followed by detergent solution (10 ng mL
-1
Proteinase K in 50 mM EDTA, 50 mM Tris-HCl [pH
8], 1% N-lauroyl sarcosine (Sigma Aldrich Chemicals,
Cat No. L9150)). The solution was then incubated over-
night at 55°C. Following this, phage DNA was extracted
using phenol: chloroform and ethanol precipitation [5].
The extracted FSH19 DNA was purified using a DNA
wizard purification kit (Promega, Cat No. A1120) then
subjected to whole genome amplification using a Repli-
G kit (Qiagen, UK Cat. No. 150023). Genomic DNA
was fragmented to 500 bp using a Covaris S2 sonicator
(Covaris Inc., USA) and libraries constructed using a
NEBNext DNA Sample Prep Master Mix Set 2 (New
England Biolabs Cat. No. E6070S). The libraries were
subsequently sequenced using the Roche 454 GS FLX
system (Roche Diagnostics, USA).
The fully sequenced FSH19 genome was annotated
using a combination of CLC Genomics Workbench (CLC
Bio, Denmark) and Artemis software [40]. For compari-
sons between the genomes of FSH19, Vi01, and SboM-
AG3, ACT software was used [41], and comparison files
were generated using the web-based programme Double-
ACT http://www.hpa-bioinfotools.org.uk/pise/double_-
act.html. Nucleotide and protein searches were
performed using the Blast search algorithm [42]. For the
identification of protein domains of known function,
searches of the Pfam databa s ew e r em a d e[ 4 3 ] ,w h i l s t
protein alignments were generated using ClustalW2 [44].
Betawrap was used to identify potential right-handed par-
allel b-helices in the tail spike proteins encoded by
FSH19, Vi01, and SboM-AG3 [45]. For the identification
of phage regulatory elements Phire analysis of the
FSH19 genome was performed [46], and tRNAscan-SE
1.21 was used to identify tRNA genes [47]. The complete
annotated FSH19 genome sequence has been deposited
in the NCBI database (Genbank Acc. No. JN126049).
Abbreviations
gp: gene product, used in the context of functional homologues to
coliphage T4 proteins.
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